HLA-A and neoplasm: We next treated immunodeficient mice engrafted with HLA-A*24:02 (SKNAS and COG-564x) and HLA-A*23:01 (NBSD) xenografts with 106 10LH- and 302LH-transduced CAR T cells once tumours reached 100–250 mm3.